We divided cancer cases into high- and low-expression groups according to the median expression level of MSH2 and mainly applied the databases of TCGA and GEO to investigate the relationship between MSH2 expression and prognosis of patients with different tumors. The gene discussed is MSH2; the disease is cancer.